NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor
The NHS Commissioning Board (operating under the name of NHS England)contractFind a Tender ↗Ref ocds-h6vhtk-028dde32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
27 Jan 2021
Description
NHS National Framework Agreement for the supply of Recombinant Von Willebrand Factor. The framework will commence on 1 February 2021 for a period of 5 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 43 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.
Scope
- Reference
- CM/PHS/20/5624
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33141530
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Security of Supply | 20% | quality | — |
| Ease of use | 15% | quality | — |
| — | 65% | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to